This session discusses the PASEF, dia-PASEF and prm-PASEF methods and explains how these methods allow researchers to perform proteomics faster, with better depth of coverage, better sensitivity, and with more confidence in their identification and quantitation.
After a summary of these methods, this session covers some of the latest applications of the timsTOF Pro and 4D-Proteomics technology to biomarker discovery and validation, immunopeptidomcs and single cell proteomics.
Gary Kruppa, Ph.D., Vice President Proteomics at Bruker Daltonics Inc., and Managing Director of Bruker S.R.O., Billerica, MA, USA
Richard Scheltema, Ph.D., Assistant Professor, Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
For Research Use Only. Not for use in clinical diagnostic procedures.